Australia, Jan. 28 -- Immunocore Ltd., owns the trademark (2498799) for 'KYOPRAME' till Aug. 13, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, urothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, hodgkin's lymphoma, and head and neck cancers.]
Type of Mark:...